Expanding Covid-19 diagnostics product portfolio
Recombinant SARS-CoV-2 Nucleocapsid Protein
As a part of our expanding Covid-19 diagnostics product portfolio, Medix Biochemica announces the availability of recombinant SARS-CoV-2 nucleocapsid protein to support diagnostic test manufacturers globally. As it is expressed in CHO cells, it provides highest quality and performance.
The novel SARS-CoV-2 N antigen can be used with well validated anti-IgG and anti-IgM antibodies in serological testing to detect SARS-CoV-2 antibodies from blood samples.
Ordering information
| Product | Product code |
| Recombinant SARS-CoV-2 N, 100 µg Recombinant SARS-CoV-2 N, 1 mg Recombinant SARS-CoV-2 N, 5 mg Anti-h IgG 7701 SPRN-5 Anti-h IgG 7701 SPRN-10 Anti-h IgM 7408 SPRN-5 |
710081 710082 710083 100087 100152 100084 |
Biological materials
In addition, patient serum and nasal swab samples, and other Covid-19 relevant biological materials are available in our portfolio, including:
- Covid-19 positive serum samples
- Covid-19 negative serum samples
- Covid-19 positive nasal swabs
- Covid-19 negative nasal swabs
- Other relevant biological materials
Please visit www.leebio.com to find out more about these products.
For further information, you can get in touch with our Technical Support: moc.acimehcoibxidem@troppushcet
